With tighter energy efficiency targets in place and a broader UK commitment to 2050 net zero, selecting the best roadmap to low-carbon heat can feel daunting for social housing providers. Rob Pearse, Residential Business Director at Baxi, outlines some of the options.
Dr William Dawson, CEO of OneMedical Group – a national health and wellbeing company delivering NHS services, system leadership and consultancy across the UK – discusses the adoption of technology and opportunities in healthcare post COVID-19.
Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.
Here, we learn about the importance of recognising Absenteeism, Presenteeism and Leaveism, so that businesses can proactively address them to reduce costs and support their workers.
Here, Rie Krabsen and Erik Christiansen of EBO Consult continue to disclose the ins and out of district heating, in particular, discussing operation and maintenance.
Here, we learn how Mile High Labs, a leading processor of hemp-derived cannabinoids, have raised Series B equity financing and are preparing for global CPG partnerships.
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.
Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.
Drs Yuping Wang and David F. Lewis from Louisiana State University Health Sciences Center – Shreveport discuss the impact of vitamin D in regulating immune tolerance and foetal development in pregnancy.
Dr Nicolas Tabareau from IMT Atlantique Bretagne-Pays de la Loire, provides us with further insight about interactive proof assistants, within the wider field of computer science, software and mathematics.
